Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.

Cell Reports
Jinkai WanFei Lan

Abstract

Coronavirus disease 2019 (COVID-19) has become a worldwide threat to humans, and neutralizing antibodies have therapeutic potential. We have purified more than 1,000 memory B cells specific to SARS-CoV-2 S1 or its RBD (receptor binding domain) and obtain 729 paired heavy- and light-chain fragments. Among these, 178 antibodies test positive for antigen binding, and the majority of the top 17 binders with EC50 below 1 nM are RBD binders. Furthermore, we identify 11 neutralizing antibodies, eight of which show IC50 within 10 nM, and the best one, 414-1, with IC50 of 1.75 nM. Through epitope mapping, we find three main epitopes in RBD recognized by these antibodies, and epitope-B antibody 553-15 could substantially enhance the neutralizing abilities of most of the other antibodies. We also find that 515-5 could cross neutralize the SARS-CoV pseudovirus. Altogether, our study provides 11 potent human neutralizing antibodies for COVID-19 as therapeutic candidates.

References

Feb 28, 2009·Nature Protocols·Kenneth SmithPatrick C Wilson
Jul 9, 2013·Lancet·Chris T Bauch, Tamer Oraby
Sep 21, 2013·Emerging Infectious Diseases·Chao QiuJianqing Xu
Mar 2, 2016·Journal of Autoimmunity·Christopher ChangM Eric Gershwin
May 18, 2016·Scientific Reports·Qi ZhangLinqi Zhang
Sep 8, 2016·Journal of Immunological Methods·Irvin Y HoPatrick C Wilson
Oct 13, 2016·The New England Journal of Medicine·UNKNOWN PREVAIL II Writing GroupDenis Malvy
May 6, 2017·Cell·Davide F RobbianiMichel C Nussenzweig
Aug 14, 2018·Science Advances·V Stalin RajBart L Haagmans
May 10, 2019·Bioinformatics·Alexey M KozlovAlexandros Stamatakis
Feb 23, 2020·Science·Daniel WrappJason S McLellan
Mar 3, 2020·The Lancet Infectious Diseases·Long ChenYuan Shi
Mar 4, 2020·Nature Microbiology·UNKNOWN Coronaviridae Study Group of the International Committee on Taxonomy of Viruses
Mar 11, 2020·Cell·Alexandra C WallsDavid Veesler
Mar 24, 2020·Nature·Ewen CallawayJeff Tollefson
May 6, 2020·Nature Communications·Chunyan WangBerend-Jan Bosch
May 16, 2020·Cell Host & Microbe·Yanling WuTianlei Ying

❮ Previous
Next ❯

Citations

Jun 15, 2020·Allergy·Carmen RiggioniCezmi A Akdis
Aug 26, 2020·Pathogens and Disease·Jitendra Singh Rathore, Chaitali Ghosh
Sep 18, 2020·Expert Opinion on Therapeutic Targets·Shibo JiangLanying Du
Aug 25, 2020·Journal of Medical Virology·Ji-Ming Chen
Sep 29, 2020·SN Comprehensive Clinical Medicine·Nevio Cimolai
Oct 15, 2020·Signal Transduction and Targeted Therapy·Yetian DongFangfang Zhou
Nov 25, 2020·Current Opinion in HIV and AIDS·Pilar MendozaChristian Gaebler
Dec 16, 2020·SLAS Discovery·Dawid MaciorowskiAdinarayana Kunamneni
Sep 30, 2020·Cytotherapy·Kuttuvan Valappil Sajna, Siya Kamat
Jan 7, 2021·Trends in Immunology·Liriye Kurtovic, James G Beeson
Dec 21, 2020·Stem Cell Research·Shi XiaojieQiang Min
Feb 2, 2021·The Journal of Biological Chemistry·Youjia GuoKensaku Murano
Nov 17, 2020·SN Comprehensive Clinical Medicine·Nevio Cimolai
Sep 2, 2020·JCI Insight·Kento T AbeAnne-Claude Gingras
Feb 17, 2021·EClinicalMedicine·Seiya YamayoshiYoshihiro Kawaoka
Dec 20, 2020·Nature Reviews. Immunology·Lianpan Dai, George F Gao
Jan 16, 2021·Proceedings of the National Academy of Sciences of the United States of America·Varun SasisekharanUma Narayanasami
Oct 19, 2020·Biochemical and Biophysical Research Communications·Meng YuanIan A Wilson
Jan 5, 2021·Genome Génome / Conseil National De Recherches Canada·Rwik SenYanan Lu
Mar 10, 2021·Journal of Thrombosis and Thrombolysis·Richard C Becker, Christoph Bode
Mar 2, 2021·Frontiers in Pharmacology·Zhihong ZuoMeichun Deng
Mar 18, 2021·Immune Network·Erica EspañoJeong-Ki Kim
Mar 25, 2021·Signal Transduction and Targeted Therapy·Cheng LiTianlei Ying
Apr 4, 2021·International Journal of Environmental Research and Public Health·Omar NyabiJean-Luc Gala
Oct 13, 2020·Trends in Immunology·Edem GavorJ Sivaraman
Apr 15, 2021·ACS Infectious Diseases·Cheng WangJunping Wang
Apr 24, 2021·Microbial Cell Factories·Norma A Valdez-CruzMauricio A Trujillo-Roldán
Apr 12, 2021·Journal of Molecular Biology·Frederic A FellouseStephen W Michnick
May 11, 2021·Human Genomics·Giuseppe NovelliJuergen K V Reichardt
May 15, 2021·Frontiers in Cell and Developmental Biology·Wenrui JiaZheng Zhou
May 22, 2021·Viral Immunology·Noha A KamelKhaled M Aboshanab
May 7, 2021·The Journal of Immunology : Official Journal of the American Association of Immunologists·Grace MantusJens Wrammert
Jun 12, 2021·Biochemical and Biophysical Research Communications·Dongfu JinJian Sun

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
fluorescence activated cell sorting
flow cytometry
PCR

Software Mentioned

Prism
GraphPad
Pymol
GraphPad Prism

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.